• LAST PRICE
    0.7424
  • TODAY'S CHANGE (%)
    Trending Up0.0149 (2.0481%)
  • Bid / Lots
    0.7130/ 10
  • Ask / Lots
    0.7890/ 50
  • Open / Previous Close
    0.7319 / 0.7275
  • Day Range
    Low 0.7302
    High 0.7600
  • 52 Week Range
    Low 0.5800
    High 5.3300
  • Volume
    304,753
    average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Monday's close: 0.7275
TimeVolumeALVR
09:32 ET2990.7319
09:34 ET5530.7439
09:43 ET1500.7344
09:52 ET1000.7302
09:57 ET1000.7303
10:15 ET1000.7306
10:30 ET1000.7539
10:33 ET1000.7312
11:02 ET1360.74265
11:06 ET17010.7406
11:09 ET27510.7398
11:11 ET2290.748
11:13 ET1000.748
11:15 ET4270.7398
11:18 ET1000.748
11:20 ET4800.748
11:22 ET1250.7423
11:26 ET2240.7423
11:31 ET1240.7455
11:36 ET1230.74525
11:42 ET1180.74525
11:45 ET23000.751
11:51 ET2160.7455
11:56 ET4270.751
12:02 ET1150.7455
12:05 ET1110.7455
12:12 ET1110.7455
12:16 ET61640.749
12:18 ET76040.7499
12:20 ET1000.7497
12:21 ET5070.7497
12:23 ET2000.7497
12:25 ET2080.74485
12:27 ET3000.7497
12:32 ET3060.7497
12:34 ET5000.7497
12:36 ET2050.74485
12:38 ET2000.7497
12:39 ET119000.74485
12:41 ET9040.7475
12:43 ET12000.7474
12:45 ET22050.7473
12:48 ET1000.74365
12:50 ET1000.74365
12:52 ET3030.74365
12:54 ET2000.7472
12:56 ET2020.7436
12:57 ET7000.7472
01:01 ET2240.740101
01:03 ET2000.7471
01:06 ET1100.74355
01:08 ET1000.74745
01:10 ET16910.74745
01:12 ET4050.7475
01:14 ET2000.74745
01:15 ET1040.74745
01:17 ET9000.7474
01:19 ET12430.75
01:21 ET3000.75
01:24 ET2000.75
01:26 ET3030.7487
01:28 ET1000.7487
01:30 ET1000.75
01:32 ET1060.7487
01:33 ET1000.7487
01:35 ET1070.7487
01:37 ET6000.7499
01:42 ET115000.75
01:44 ET116330.75
01:46 ET6060.7487
01:48 ET2000.74935
01:50 ET1000.7499
01:51 ET82870.7469
01:55 ET1430.7435
02:04 ET14400.7469
02:06 ET3000.7444
02:08 ET142680.7445
02:09 ET2910.7445
02:11 ET55130.7468
02:13 ET1000.7462
02:15 ET4000.7466
02:18 ET2000.7466
02:20 ET2000.7466
02:22 ET8000.7466
02:24 ET2000.7433
02:29 ET6000.7466
02:31 ET12000.7466
02:33 ET5590.7474
02:36 ET102000.748
02:38 ET1000.75
02:42 ET4000.748
02:44 ET29320.75
02:45 ET14040.75
02:47 ET5000.75
02:49 ET2000.75
02:51 ET2000.75
02:54 ET1000.75005
02:56 ET4000.75
02:58 ET1000.7502
03:00 ET3000.75005
03:02 ET272680.753
03:03 ET11000.756
03:05 ET13720.75515
03:07 ET2000.7513
03:09 ET18690.75
03:14 ET1000.7513
03:16 ET1000.7513
03:18 ET1000.743
03:20 ET8000.7469
03:21 ET1000.7423
03:23 ET280970.7414
03:25 ET1000.74385
03:30 ET1000.74385
03:32 ET6000.7439
03:34 ET3000.7477
03:36 ET13000.7425
03:38 ET6000.7425
03:39 ET16000.7449
03:41 ET23690.7449
03:43 ET5640.7402
03:45 ET16000.7401
03:48 ET2000.7401
03:50 ET12000.7425
03:52 ET2000.7401
03:54 ET11000.7401
03:56 ET74940.7425
03:57 ET25230.7401
03:59 ET170040.7424
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesALVR
Allovir Inc
85.4M
-0.4x
---
United StatesPMVP
PMV Pharmaceuticals Inc
82.8M
-1.2x
---
United StatesVSTM
Verastem Inc
82.8M
-0.7x
---
United StatesDMAC
DiaMedica Therapeutics Inc
88.1M
-4.2x
---
United StatesIOBT
IO Biotech Inc
82.4M
-0.7x
---
United StatesCNTB
Connect Biopharma Holdings Ltd
82.1M
-1.4x
---
As of 2024-06-19

Company Information

AlloVir, Inc. is an allogeneic T cell immunotherapy company with a focus on restoring natural immunity against life-threatening viral diseases in pediatric and adult patients with weakened immune systems. The company’s proprietary technology platforms leverage off-the-shelf, allogeneic, single- and multi-virus-specific T cells for patients with T cell deficiencies who are at risk from the life-threatening consequences of viral diseases. Its technology and manufacturing process enable the potential for the treatment and prevention of a spectrum of devastating viruses with each single allogeneic cell therapy. Its lead product candidate, posoleucel, is a multi-VST therapy that targets six viruses: adenovirus (BKV), cytomegalovirus (EBV), human herpesvirus 6 (HHV-6) and JC virus (JCV). Its proprietary VST manufacturing platform enables the rapid, robust and reproducible generation of single-virus and multi-virus specific cell therapeutic candidates for clinical use.

Contact Information

Headquarters
1100 Winter StreetWALTHAM, MA, United States 02451
Phone
617-433-2605
Fax
302-655-5049

Executives

Executive Chairman of the Board
David Hallal
President, Chief Financial Officer, Director
Vikas Sinha
Chief Executive Officer, Director
Diana Brainard
Co-Founder, Chief Scientific Officer
Ann Leen
Chief Accounting Officer
Brett Hagen

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$85.4M
Revenue (TTM)
$0.00
Shares Outstanding
115.0M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.77
EPS
$-1.65
Book Value
$1.28
P/E Ratio
-0.4x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.